Weiss Multi Strategy Advisers LLC Eli Lilly & CO Put Options Transaction History

Weiss Multi Strategy Advisers LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.48 Million - $1.69 Million	5,000 New	5,000 $1.62 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $10.7 Million - $13.2 Million	-100,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $10.7 Million - $11.6 Million	100,000 New	100,000 $11.2 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $556,550 - $655,100	-5,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $529,500 - $593,200	5,000 New	5,000 $579,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.